Nanoxort
PrivateLast Round
Accelerator
Jun 17, 2026
Total Funding Raised
$1.71M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nanoxort operates in Healthcare & Life Sciences and is based in Auburn, Alabama. Its latest recorded funding round was an Accelerator round in June 2026.
Nanoxort is a biomedical company that develops iron-based MRI contrast agents as a safer, gadolinium-free alternative for medical imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanoxort Comparables
Compare Nanoxort with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reveal Pharmaceuticals | 83% | |
| SPL Medical B.V. | 78% | |
| MegaPro Biomedical Co., Ltd. | 77% |
For institutional investors. Book with your work email.
Nanoxort Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 17, 2026 | ||||
| Grant | Apr 22, 2024 | ||||
| Grant | Sep 6, 2023 | ||||
| Grant | Aug 24, 2022 | ||||
| Grant | Mar 23, 2021 | ||||
Grant | Jan 1, 2018 |
For institutional investors. Book with your work email.
Nanoxort Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alabama Launchpad | Grant |
| Auburn University LAUNCH Innovation Grants Program | Grant |
| gBETA | Accelerator |
| National Science Foundation | Grant |
| NSF I-Corps Program | Grant |
| InvestAL | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
gBETA participated in the Accelerator round.
- Apr 22, 2024
$250K grant received from InvestAL
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 10, 2026
Nanoxort develops MRI contrast agents that improve cardiovascular disease detection, extend the imaging window, and enhance safety for at-risk patients in Alabama.
For institutional investors. Book with your work email.
Nanoxort Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanoxort's valuation, stock price, and market status.
Is Nanoxort a public or private company?
Nanoxort is a private company.
What is the current stock price of Nanoxort?
Nanoxort is a private company, so its shares have no public market price. Caplight tracks Nanoxort's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanoxort worth (valuation)?
Valuation information for Nanoxort is not publicly available.
Can I buy Nanoxort stock?
Nanoxort shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanoxort's last funding round?
Nanoxort's most recent funding round was Accelerator on June 17, 2026.
Who are the main investors in Nanoxort?
Key investors in Nanoxort include Alabama Launchpad, Auburn University LAUNCH Innovation Grants Program, gBETA, National Science Foundation, NSF I-Corps Program.
Will Nanoxort IPO soon?
No public IPO plans have been announced for Nanoxort.
How can I track Nanoxort secondary market activity?
Caplight tracks bids, offers, and trades in Nanoxort's shares on secondary markets.